AN ANALYSIS OF THE REPORTING OF RESULTS IN LUNG CANCER DRUG TRIALSRUDNICK SA; FEINSTEIN AR.1980; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1980; VOL. 64; NO 6; PP. 1337-1343; BIBL. 54 REF.Article

METHOTREXATE CYTOTOXICITY FOR L5178Y/ASN^- LYMPHOBLASTS: RELATIONSHIP OF DOSE AND DURATION OF EXPOSURE TO TUMOR CELL VIABILITYKEEFE DA; CAPIZZI RL; RUDNICK SA et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 5; PP. 1641-1645; BIBL. 53 REF.Article

RANDOMIZED PHASE II COMPARISON OF METHOTREXATE WITH OR WITHOUT L-ASPARAGINASE IN NON-SMALL CELL CANCER OF THE LUNGRUDNICK SA; NEIJSTROM E; CAPIZZI RL et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 3; PP. 541-544; BIBL. 19 REF.Article

OPERATIONAL CRITERIA FOR ADVERSE DRUG REACTIONS IN EVALUATING SUSPECTED TOXICITY OF A POPULAR SCABICIDEKRAMER MS; HUTCHINSON TA; RUDNICK SA et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 2; PP. 149-155; BIBL. 28 REF.Article

HIGH-DOSE METHOTREXATE IN SMALL CELL LUNG CANCER = METHOTREXATE A FORTE DOSE DANS LE CANCER A PETITES CELLULES DU POUMONNEIJSTROM ES; CAPIZZI RL; RUDNICK SA et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 6; PP. 1056-1061; ABS. ENG; BIBL. 41 REF.; GRAPHArticle

HIGH DOSE CYTOSINE ARABINOSIDE (HDARAC) IN REFRACTORY ACUTE LEUKEMIARUDNICK SA; CADMAN EC; CAPIZZI RL et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 4; PP. 1189-1193; BIBL. 17 REF.Article

PREDICTION OF BCNU PULMONARY TOXICITY IN PATIENTS WITH MALIGNANT GLIOMAS: AN ASSESSMENT OF RISK FACTORSARONIN PA; MAHALEY MS JR; RUDNICK SA et al.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 4; PP. 183-188; BIBL. 10 REF.Article